Beneficial effects of sodium glucose cotransporter 2 inhibitors on left ventricular mass in patients with diabetes mellitus.

Daisuke KosugiHidefumi InabaYosuke KaidoSaya ItoTomonao HirobataMamoru ToyofukuTakaaki MatsuokaGen Inoue

Published in: Journal of diabetes (2021)

SGLT2i treatment was shown to improve LVH in patients with T2DM and may play a pivotal role in the future treatment of diabetic cardiovascular complications.

Keyphrases

left ventricular
heart failure
type diabetes
risk factors
acute myocardial infarction
combination therapy
metabolic syndrome
adipose tissue
coronary artery disease
skeletal muscle
aortic valve
aortic stenosis
weight loss
ejection fraction